Search for: "Glenmark Generics Limited"
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
8 Feb 2011, 7:19 am
Glenmark Pharmaceuticals Inc., USA, et. al., 2-07-cv-05855 (NJD February 3, 2011, Order) (Cavanaugh, J.) [read post]
21 Feb 2013, 3:45 pm
Anyway, spotting a recent decision from the Patents Court, England and Wales, by the name of Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & and Glaxo Group Ltd [2013] EWHC 148 (Pat), his first thought was that it must have something to do with alcohol. [read post]
7 Jul 2022, 4:34 am
This indicates that the Court, on one hand, held a door open so that enforcement after a ‘decision to grant’ has been made by the EPO would be possible, but on the other hand generally rejected enforcement prior to a ‘decision to grant’.The Court also noted that there was a risk (although the Court deemed such a risk to be limited) that the patent could still be amended.Consequently, the Court ruled that Novartis had not lifted its burden of proof with… [read post]
21 Oct 2014, 12:00 am
In Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & Glaxo Group Ltd, [2013] EWHC 148 (Pat), reported by the IPKat here, Arnold J decided that a combination product for treating malaria was obvious. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
28 Apr 2013, 10:39 pm
The text is due to be transmitted to the WIPO General Assembly in September, 2013. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
11 Nov 2017, 11:00 am
Glenmark Pharm.Inc., USA, 204 F. [read post]
14 Jul 2010, 6:47 pm
(EPLAW) EU Court of Justice limits scope of patent protection available to gene sequences: Monsanto v. [read post]
26 Aug 2009, 6:12 am
The Corporate Gold Rush to Patent Your Genes’ perpetuates popular misperceptions surrounding gene patents (Holman's Biotech IP Blog) Australian pharmaceutical patent term extension for patches and implants: N V Organon; LTS Lohmann Therapie-Systeme AG and Schwarz Pharma Limited (Patent Baristas) China: Obama Administration and compulsory licensing in China (China Hearsay) China: Forty-two of Simcere’s generic drugs enter China’s Essential Drug… [read post]
5 Dec 2008, 1:00 pm
FDA issues draft guidance on submission of patent information for certain old antibiotics (FDA Law Blog) US: FDA publishes new guidance on contents of a complete submission for the evaluation of proprietary names (FDA Law Blog) USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360) (Law360)… [read post]
11 Mar 2015, 9:15 am
The international arm of US drugmaker Merck&Co. and Glenmark agreed to mediate and settle the patent infringement that has been filed by the former MNC against the latter generic drugmaker for launching generic copies of two of its diabetic drugs Januvia and Janumet in the Indian market in 2013. [read post]
30 Jun 2013, 1:12 pm
Incidentally, the High Court denied interim relief to Merck against Glenmark for the same drug, a fact which doesn't find any mention in the latest order against Aprica. [read post]
18 Aug 2010, 12:19 am
Apotex Pty Ltd; CSL Limited v. [read post]
17 Nov 2010, 1:48 am
General Where in the world is pharmaceutical innovation? [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]
5 Sep 2008, 11:01 pm
: (Excess Copyright), (Michael Geist), Opinion and analysis of C-61: (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), 61 reforms to C-61: (Day 50: Education harms – lessons contain limited definition of students – Michael Geist), (Day 51: Education internet exception is unnecessary – Michael Geist), (Day 52: Education internet exception is harmful – Michael Geist), (Day 53: Education internet… [read post]
